首页 › 基金 › Ally Bridge Group (NY) LLC › TRAX

Ally Bridge Group (NY) LLC 对 TRAX 的持仓历史

FIRST TRACKS BIOTHERAPEUTICS ORD SHS · 医疗保健

Ally Bridge Group (NY) LLC 在 Q2 2026 的 13F 申报中披露持有 TRAX(FIRST TRACKS BIOTHERAPEUTICS ORD SHS)284,287 股,市值约 US$5.7M,约占其申报组合的 5.06%,在其申报持仓中市值排名第 5 位。 Ally Bridge Group (NY) LLC 于 Q2 2026 首次申报该持仓。

最新持仓 (Q2 2026)284.29K 股
申报持仓市值$5.72M
组合权重5.06%
首次申报Q2 2026
最近变动新进
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

Ally Bridge Group (NY) LLC 对 TRAX 的持仓演变

Ally Bridge Group (NY) LLC 于 Q2 2026 首次披露 TRAX 持仓:284,287 股(约 US$5.7M)。

逐季持仓明细

季度股数金额变化
Q2 2026 284.29K $5.72M 新进

关于 TRAX 与 13F 数据

TRAX(FIRST TRACKS BIOTHERAPEUTICS ORD SHS)属于医疗保健行业。我们追踪的基金中还有 154 只申报持有 TRAX,申报仓位最大的包括:EcoR1 Capital, LLC (US$63.9M), TCG Crossover Management, LLC (US$58.3M), Affinity Asset Advisors, LLC (US$40.9M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 TRAX 的基金

查看 TRAX 的全部基金持有人 →

常见问题

How long has Ally Bridge Group (NY) LLC held TRAX?

Ally Bridge Group (NY) LLC has disclosed TRAX holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is Ally Bridge Group (NY) LLC's current position in TRAX?

As of Q2 2026, Ally Bridge Group (NY) LLC holds 284.29K shares of TRAX (FIRST TRACKS BIOTHERAPEUTICS ORD SHS), valued at $5.72M, representing 5.06% of its reported portfolio and ranking #5.

Has Ally Bridge Group (NY) LLC been buying or selling TRAX?

In the latest 13F filing (Q2 2026), Ally Bridge Group (NY) LLC newly opened its position in TRAX.

Which other funds hold TRAX?

Other major institutional holders of TRAX include EcoR1 Capital, LLC, TCG Crossover Management, LLC, Affinity Asset Advisors, LLC, among 154 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.